Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aligos Therapeutics, Inc.
28 Feb 24
4
Aligos Therapeutics, Inc.
27 Oct 23
4
Aligos Therapeutics, Inc.
21 Jul 23
4
Aligos Therapeutics, Inc.
27 Jun 22
4
Entrada Therapeutics, Inc.
6 Jun 22
4
Entrada Therapeutics, Inc.
1 Nov 21
3
Entrada Therapeutics, Inc.
28 Oct 21
4
Aligos Therapeutics, Inc.
17 Jun 21
4
Aligos Therapeutics, Inc.
20 Oct 20
3
Aligos Therapeutics, Inc.
15 Oct 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 4,411 | 4.23 k | 4,411 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 26.58 | 15,000 | 398.70 k | 0 |
25 Oct 23 | ALGS Aligos Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 0.7568 | 7,933,601 | 6.00 mm | 11,025,941 |
25 Oct 23 | ALGS Aligos Therapeutics | Warrant Common Stock | Buy | Acquire P | Yes | No | 0.125 | 3,966,800 | 495.85 k | 3,966,800 |
20 Jul 23 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 20,000 | 20.00 k | 20,000 |